PTGX | Protagonist Therapeutics, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	42.44 - 47.50
52 Week Range	16.80 - 48.89
Beta	2.33
Implied Volatility	74.62%
IV Rank	26.89%
Day's Volume	1,271,683
Average Volume	653,339
Shares Outstanding	59,598,000
Market Cap	2,768,923,080
Sector	Healthcare
Industry	Biotechnology
IPO Date	2016-08-11

Valuation
Profitability
Growth
Health
P/E Ratio	16.96
Forward P/E Ratio	N/A
EPS	2.74
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	125
Country	USA
Website	PTGX

Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with polycythemia vera and hereditary hemochromatosis, as well as for the treatment of other blood disorders; PN-943, an oral, alpha-4-beta-7 integrin- specific antagonist peptide that is in Phase II clinical trials for treating inflammatory bowel disease (IBD); and PN-235, an orally delivered interleukin-23 receptor specific antagonist for the treatment of IBD and non-IBD indications. The company has a license and collaboration agreement with Janssen Biotech, Inc. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

PTGX's peers: ADCT, AKRO, COGT, HALO, HRMY, IDYA, IMVT, INBX, JAZZ, KURA, MDXG, MGNX, MRSN, MRUS, MRVI, OMER, PGEN, RVMD, RNA, STOK, REPL, CERE, RLAY, PLRX, BDTX, ARVN, VTYX, VRNA, SNDX, TERN, XFOR, ABOS, DAWN, HOOK, QURE, RGNX, RYTM, TSVT, TVTX, VCYT, VRDN, XNCR, ZNTL, ZYME, PROK

*Chart delayed

Analyzing fundamentals for PTGX we got that it has average fundamentals where Valuation is considered to be slightly overvalued, Profitability is stunning wealthy, Growth is bad and Health is strong. For more detailed analysis please see PTGX Fundamentals page.

Watching at PTGX technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on PTGX Technicals page.